Based on the analysis of NextTrip's profitability, liquidity, and operating efficiency, NextTrip is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in January. At this time, NextTrip's Non Current Assets Total are relatively stable compared to the past year. As of 12/03/2024, Total Liabilities is likely to grow to about 2.1 M, while Cash is likely to drop slightly above 307.6 K. Key indicators impacting NextTrip's financial strength include:
The essential information of the day-to-day investment outlook for NextTrip includes many different criteria found on its balance sheet. An individual investor should monitor NextTrip's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in NextTrip.
NextTrip competes with Cardinal Health, Meiwu Technology, Grocery Outlet, National Vision, and Coupang LLC. Neurotrope, Inc., a biopharmaceutical company, focuses on the development of a product platform for the treatment of Alzheimers disease. The company was founded in 2012 and is based in New York, New York. Neurotrope operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.
The reason investors look at the income statement is to determine what NextTrip's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining NextTrip's current stock value. Our valuation model uses many indicators to compare NextTrip value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NextTrip competition to find correlations between indicators driving NextTrip's intrinsic value. More Info.
NextTrip is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . At this time, NextTrip's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value NextTrip by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
NextTrip Systematic Risk
NextTrip's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NextTrip volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on NextTrip correlated with the market. If Beta is less than 0 NextTrip generally moves in the opposite direction as compared to the market. If NextTrip Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NextTrip is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NextTrip is generally in the same direction as the market. If Beta > 1 NextTrip moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in NextTrip Stock are looking for potential investment opportunities by analyzing not only static indicators but also various NextTrip's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of NextTrip growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of NextTrip help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NextTrip. We use our internally-developed statistical techniques to arrive at the intrinsic value of NextTrip based on widely used predictive technical indicators. In general, we focus on analyzing NextTrip Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NextTrip's daily price indicators and compare them against related drivers.
When running NextTrip's price analysis, check to measure NextTrip's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextTrip is operating at the current time. Most of NextTrip's value examination focuses on studying past and present price action to predict the probability of NextTrip's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextTrip's price. Additionally, you may evaluate how the addition of NextTrip to your portfolios can decrease your overall portfolio volatility.